Standards & Regulation

How can we overcome red tape and roadblocks to ensure a steady supply of pharmaceutical ingredients?

After other defendants in the case settle, Teva is left to face the music in New York alone.

A new report has exposed a Humira US price hike that dwarfs the rises in the price of other drugs.

Panels, thought leaders, and spicy opinions! Here’s a roundup of our best video content of 2021.

Can digital approaches help improve pharmacovigilance practices?

New ICH guideline revisions are imminent. Sue Batchelor of Cmed shares her thoughts on how sponsors and CROs can prepare themselves.

AppliedVR gets FDA OK to market virtual reality system for chronic pain.

A quick look at reactions across the US to Biden’s Build Back Better bill.

The EMA has given the nod to Ronapreve and Regkirona, two monoclonal antibody treatments for COVID-19.

After a madcap back and forth between leading and dissenting Democrats, Biden’s drug pricing reform plans have reached a compromised final form.